DOMS Industries (DOMS) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
20 Nov, 2025Executive summary
Achieved consolidated revenue growth of 24.4% year-over-year, driven by core categories, new product launches, and strategic acquisitions including Uniclan and SKIDO.
Strengthened global presence and export capabilities through FILA partnership and exclusive distribution rights.
Continued investment in manufacturing infrastructure, R&D, and capacity expansion to support operational efficiency and product innovation.
Board recommended a dividend of INR 3.15 per share, subject to approval.
Hygiene segment reported separately for the first time, reflecting impact of recent acquisitions.
Financial highlights
Q4 FY25 revenue grew 26% year-over-year to INR 508.7 crores; FY25 revenue reached INR 1,912.6 crores, up 24.4%.
Q4 FY25 EBITDA rose 16.2% to INR 88.3 crores; FY25 EBITDA up 27.8% to INR 348.4 crores with margin at 18.2%.
Q4 FY25 PAT increased 9.3% to INR 51.3 crores; FY25 PAT up 33.7% to INR 213.5 crores with margin at 11.2%.
Gross profit margin for FY25 at 43.5%, up from 41.9% in FY24.
Operating cash flow for FY25 at INR 183.3 crores; significant investments in capex and acquisitions.
Outlook and guidance
Revenue growth guidance for FY2026 is 18%-20% at consolidated level, including Uniclan.
EBITDA margin expected in the 16.5%-17.5% range; PAT margin around 10%.
CapEx planned at INR 225-250 crores annually for the next two years, focused on plant expansion and capacity additions.
Ongoing capacity expansion at Umbergaon, Gujarat, with first building to be operational by Q4FY26.
Unutilized IPO proceeds remain invested in fixed deposits and monitoring accounts, supporting future growth.
Latest events from DOMS Industries
- Q3 FY26 delivered 18.2% sales growth, 17.5% EBITDA margin, and major capacity expansion.DOMS
Q3 25/262 Feb 2026 - Q1 FY25 saw strong revenue and profit growth, margin expansion, and strategic diversification.DOMS
Q1 24/252 Feb 2026 - Q2 FY25 revenue and profit rose sharply, aided by Uniclan acquisition and margin expansion.DOMS
Q2 24/2515 Jan 2026 - Q3 FY25 revenue up 35% YoY, PAT up 40%, driven by growth, expansion, and acquisitions.DOMS
Q3 24/259 Jan 2026 - Q1 FY26 revenue rose 26.4% with strong margins, capacity expansion, and new product launches.DOMS
Q1 25/2623 Nov 2025 - Q2 FY26 delivered strong revenue and profit growth, with expansion and reforms supporting future gains.DOMS
Q2 25/2611 Nov 2025